Your browser doesn't support javascript.
loading
Scalable generation of universal platelets from human induced pluripotent stem cells.
Feng, Qiang; Shabrani, Namrata; Thon, Jonathan N; Huo, Hongguang; Thiel, Austin; Machlus, Kellie R; Kim, Kyungho; Brooks, Julie; Li, Feng; Luo, Chenmei; Kimbrel, Erin A; Wang, Jiwu; Kim, Kwang-Soo; Italiano, Joseph; Cho, Jaehyung; Lu, Shi-Jiang; Lanza, Robert.
Afiliação
  • Feng Q; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Shabrani N; Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612, USA.
  • Thon JN; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115.
  • Huo H; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Thiel A; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Machlus KR; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115.
  • Kim K; Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612, USA.
  • Brooks J; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Li F; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Luo C; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Kimbrel EA; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Wang J; Allele Biotechnology, San Diego, CA 92121, USA.
  • Kim KS; MacLean Hospital, Harvard Medical School, Belmont, MA 02478, USA.
  • Italiano J; Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115, USA; Harvard Medical School, Boston, MA 02115; Vascular Biology Program, Department of Surgery, Boston Children's Hospital, Boston, MA 02115, USA.
  • Cho J; Department of Pharmacology, University of Illinois College of Medicine, Chicago, IL 60612, USA.
  • Lu SJ; Advanced Cell Technology, Marlborough, MA 01752, USA.
  • Lanza R; Advanced Cell Technology, Marlborough, MA 01752, USA. Electronic address: rlanza@advancedcell.com.
Stem Cell Reports ; 3(5): 817-31, 2014 Nov 11.
Article em En | MEDLINE | ID: mdl-25418726
ABSTRACT
Human induced pluripotent stem cells (iPSCs) provide a potentially replenishable source for the production of transfusable platelets. Here, we describe a method to generate megakaryocytes (MKs) and functional platelets from iPSCs in a scalable manner under serum/feeder-free conditions. The method also permits the cryopreservation of MK progenitors, enabling a rapid "surge" capacity when large numbers of platelets are needed. Ultrastructural/morphological analyses show no major differences between iPSC platelets and human blood platelets. iPSC platelets form aggregates, lamellipodia, and filopodia after activation and circulate in macrophage-depleted animals and incorporate into developing mouse thrombi in a manner identical to human platelets. By knocking out the ß2-microglobulin gene, we have generated platelets that are negative for the major histocompatibility antigens. The scalable generation of HLA-ABC-negative platelets from a renewable cell source represents an important step toward generating universal platelets for transfusion as well as a potential strategy for the management of platelet refractoriness.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Megacariócitos / Diferenciação Celular / Células-Tronco Pluripotentes Induzidas Limite: Animals / Humans / Male Idioma: En Revista: Stem Cell Reports Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Plaquetas / Megacariócitos / Diferenciação Celular / Células-Tronco Pluripotentes Induzidas Limite: Animals / Humans / Male Idioma: En Revista: Stem Cell Reports Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Estados Unidos